Both in Pharmaceuticals
Crescent Biopharma vs Climb Bio
Over the past year CBIO returned +11.1% and CLYM returned +396.3%; their daily moves had a correlation of 0.22.
CBIO +11.1% CLYM +396.3%Growth of $1, one year, split-adjusted
| Metric | CBIO | CLYM |
|---|---|---|
| Price | $13.82 | $9.33 |
| Market cap | $513.4M | $535.9M |
| Today | +5.82% | −4.31% |
| 1 month | +1.8% | −12.6% |
| 6 months | −23.5% | −23.6% |
| Year to date | +16.5% | +133.3% |
| 1 year | +11.9% | +366.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 43.2× | — |
| Net cash | $171.6M | $183.1M |
| Dividend yield | — | — |
| Volatility (60d) | 69.7% | 80.8% |
| Short % of float | 21.2% | 25.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).